SCHEMBL8443175

SCHEMBL8443175

CCCCc1ccc(C2(CC=O)CC2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.41
HSD17B10 Q99714 2/20 0.41
HPGD P15428 1/20 0.41
THRA P10827 2/20 0.41
THRB P10828 2/20 0.41
CA2 P00918 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
OPRL1 P41146 1/20 0.39
CA1 P00915 1/20 0.39
CRHBP P24387 1/20 0.39
HTT P42858 1/20 0.39
CRHR2 Q13324 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
RARB P10826 1/20 0.38
ENPP2 Q13822 1/20 0.38
PLK1 P53350 1/20 0.38
CYP3A4 P08684 2/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
GPR84 Q9NQS5 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5394263 0.73 ALDH1A1 (0.53) ALDH1A1HSD17B10HPGDTHRATHRB
SCHEMBL10726430 0.72 NQO1 (0.47) ALDH1A1CA2CA1HTTKDM4E
SCHEMBL16593920 0.72 CNR2 (0.45) ALDH1A1HSD17B10HPGDCA2OPRL1
SCHEMBL1952022 0.71 ALDH1A1 (0.42) ALDH1A1CA2SMN1; SMN2OPRL1CA1
SCHEMBL5074036 0.71 TSHR (0.54) ALDH1A1HSD17B10HPGDTHRATHRB
SCHEMBL19207570 0.71 MAOA (0.54) SMN1; SMN2OPRL1HTTNPSR1CYP2C9
SCHEMBL8161742 0.71 ALDH1A1 (0.52) ALDH1A1HSD17B10HPGDTHRATHRB
SCHEMBL27551549 0.71 ALDH1A1 (0.49) ALDH1A1HSD17B10HPGDTHRATHRB
SCHEMBL10927156 0.71 CNR2 (0.44) ALDH1A1CRHBPHTTCRHR2NPSR1
Formic Acid SCHEMBL28060935 0.70 ALDH1A1 (0.61) ALDH1A1HSD17B10HPGDTHRATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0900198-A1 NEW VITAMIN D DERIVATIVES WITH CARBO- OR HETEROCYCLIC SUBSTITUENTS AT C-25, A PROCESS FOR THEIR PRODUCTION, INTERMEDIATE PRODUCTS AND THEIR USE FOR PRODUCING MEDICAMENTS Schering Aktiengesellschaft (DE) 1999-03-10 EP disclosed
WO-1997041096-A1 NEW VITAMIN D DERIVATIVES WITH CARBO- OR HETEROCYCLIC SUBSTITUENTS AT C-25, A PROCESS FOR THEIR PRODUCTION, INTERMEDIATE PRODUCTS AND THEIR USE FOR PRODUCING MEDICAMENTS SCHERING AKTIENGESELLSCHAFT (DE) 1997-11-06 WO disclosed